/ Published in 2010, Publication

Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.

Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.

Watson-Jones D, Wald A, Celum C, Lingappa J, Weiss HA, Changalucha J, Baisley K, Tanton C, Hayes RJ, Marshak JO, Gladden RG, Koelle DM.
J Clin Microbiol. 2010 Oct;48(10):3496-503. Epub 2010 Aug 11.
PMID: 20702659
Related citation

What you can read next

Understanding barriers and facilitators to clinic attendance and medication adherence among adults with hypertensive urgency in Tanzania.
Vaginal practices diary: development of a pictorial data collection tool for sensitive behavioral data
A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) – Study protocol for a randomised controlled trial.